JCO Global Oncology (Nov 2020)
Creating a Global Community of Practice for Oncofertility
- Lauren M. Ataman,
- Jhenifer K. Rodrigues,
- Ricardo M. Marinho,
- João P.J. Caetano,
- Maurício B. Chehin,
- Eduardo L. Alves da Motta,
- Paulo Serafini,
- Nao Suzuki,
- Tatsuro Furui,
- Seido Takae,
- Yodo Sugishita,
- Ken-Ichiro Morishige,
- Teresa Almeida-Santos,
- Cláudia Melo,
- Karen Buzaglo,
- Kate Irwin,
- W. Hamish Wallace,
- Richard A. Anderson,
- Roderick T. Mitchell,
- Evelyn E. Telfer,
- Satish K. Adiga,
- Antoinette Anazodo,
- Catharyn Stern,
- Elizabeth Sullivan,
- Yasmin Jayasinghe,
- Lisa Orme,
- Richard Cohn,
- Rob McLachlan,
- Rebecca Deans,
- Franca Agresta,
- Brigitte Gerstl,
- William L. Ledger,
- Rebecca L. Robker,
- João M. de Meneses e Silva,
- Lígia H.F. Melo e Silva,
- Franciele O. Lunardi,
- Jung R. Lee,
- Chang S. Suh,
- Michael De Vos,
- Ellen Van Moer,
- Dominic Stoop,
- Veerle Vloeberghs,
- Johan Smitz,
- Herman Tournaye,
- Ludwig Wildt,
- Katharina Winkler-Crepaz,
- Claus Y. Andersen,
- Brigid M. Smith,
- Kristin Smith,
- Teresa K. Woodruff
Affiliations
- Lauren M. Ataman
- Feinberg School of Medicine, Northwestern University, Chicago, IL
- Jhenifer K. Rodrigues
- Brazilian Oncofertility Consortium, Belo Horizonte, Brazil
- Ricardo M. Marinho
- Brazilian Oncofertility Consortium, Belo Horizonte, Brazil
- João P.J. Caetano
- Brazilian Oncofertility Consortium, Belo Horizonte, Brazil
- Maurício B. Chehin
- Brazilian Oncofertility Consortium, Belo Horizonte, Brazil
- Eduardo L. Alves da Motta
- Brazilian Oncofertility Consortium, Belo Horizonte, Brazil
- Paulo Serafini
- Brazilian Oncofertility Consortium, Belo Horizonte, Brazil
- Nao Suzuki
- St Marianna University School of Medicine, Knagawa, Japan
- Tatsuro Furui
- Gifu University Graduate School of Medicine, Gifu, Japan
- Seido Takae
- St Marianna University School of Medicine, Knagawa, Japan
- Yodo Sugishita
- St Marianna University School of Medicine, Knagawa, Japan
- Ken-Ichiro Morishige
- Gifu University Graduate School of Medicine, Gifu, Japan
- Teresa Almeida-Santos
- University Hospital of Coimbra, Coimbra, Portugal
- Cláudia Melo
- University of Coimbra, Coimbra, Portugal
- Karen Buzaglo
- Clinique Ovo, Montreal, Quebec, Canada
- Kate Irwin
- Cancer Knowledge Network, Milton, Ontario, Canada
- W. Hamish Wallace
- Edinburgh Royal Hospital for Sick Children, Edinburgh, United Kingdom
- Richard A. Anderson
- Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
- Roderick T. Mitchell
- Edinburgh Royal Hospital for Sick Children, Edinburgh, United Kingdom
- Evelyn E. Telfer
- Centres for Fertility Preservation and Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
- Satish K. Adiga
- Kasturba Medical College, Manipal University, Manipal, India
- Antoinette Anazodo
- Sydney Children’s and Prince of Wales Hospital, Future Fertility, Randwick, New South Wales, Australia
- Catharyn Stern
- Royal Women’s Hospital, University of Melbourne, Melbourne, Victoria, Australia
- Elizabeth Sullivan
- University of Technology, Sydney, New South Wales, Australia
- Yasmin Jayasinghe
- Children’s Cancer Centre, Royal Children’s Hospital, Parkville, Victoria, Australia
- Lisa Orme
- Children’s Cancer Centre, Royal Children’s Hospital, Parkville, Victoria, Australia
- Richard Cohn
- Kids Cancer Centre, Sydney Children’s Hospital Sydney, New South Wales, Australia
- Rob McLachlan
- Monash Institute of Medical Research, Prince Henry’s Institute, Clayton, Victoria, Australia
- Rebecca Deans
- School of Women’s and Children’s Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales, Australia
- Franca Agresta
- Royal Women’s Hospital, University of Melbourne, Melbourne, Victoria, Australia
- Brigitte Gerstl
- Sydney Children’s and Prince of Wales Hospital, Future Fertility, Randwick, New South Wales, Australia
- William L. Ledger
- School of Women’s and Children’s Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales, Australia
- Rebecca L. Robker
- Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia
- João M. de Meneses e Silva
- Ceara Blood Center, Centro de Hematologia e Hemoterapia do Ceará, Fortaleza, Brazil
- Lígia H.F. Melo e Silva
- Federal University of Ceara and Femini Imagem and Ultravida Clinic, Fortaleza, Brazil
- Franciele O. Lunardi
- State University of Ceara, Fortaleza, Brazil
- Jung R. Lee
- Seoul National University Bundang Hospital, Seongnam
- Chang S. Suh
- Seoul National University Bundang Hospital, Seongnam
- Michael De Vos
- Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium
- Ellen Van Moer
- Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium
- Dominic Stoop
- Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium
- Veerle Vloeberghs
- Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium
- Johan Smitz
- Laboratory of Clinical Chemistry and Radioimmunology, UZ Brussel, Brussels, Belgium
- Herman Tournaye
- Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium
- Ludwig Wildt
- Innsbruck Medical University, Innsbruck, Austria
- Katharina Winkler-Crepaz
- Innsbruck Medical University, Innsbruck, Austria
- Claus Y. Andersen
- Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark
- Brigid M. Smith
- Feinberg School of Medicine, Northwestern University, Chicago, IL
- Kristin Smith
- Feinberg School of Medicine, Northwestern University, Chicago, IL
- Teresa K. Woodruff
- Feinberg School of Medicine, Northwestern University, Chicago, IL
- DOI
- https://doi.org/10.1200/GO.22.00007
- Journal volume & issue
-
no. 6
pp. 317 – 330
Abstract
Fertility preservation in the cancer setting, known as oncofertility, is a field that requires cross-disciplinary interaction between physicians, basic scientists, clinical researchers, ethicists, lawyers, educators, and religious leaders. Funded by the National Institutes of Health, the Oncofertility Consortium (OC) was formed to be a scientifically grounded, transparent, and altruistic resource, both intellectual and monetary, for building this new field of practice capable of addressing the unique needs of young patients with cancer. The OC has expanded its attention to include other nonmalignant conditions that can threaten fertility, and the work of the OC now extends around the globe, involving partners who together have created a community of shared effort, resources, and practices. The OC creates materials that are translated, disseminated, and amended by all participants in the field, and local programs of excellence have developed worldwide to accelerate the pace and improve the quality of oncofertility research and practice. Here we review the global oncofertility programs and the capacity building activities that strengthen these research and clinical programs, ultimately improving patient care.
